Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 215 for “"nf1"”.
-
Decoding Nf1 Intragenic Copy-Number Changes
… disorder neurofibromatosis type 1 (NF1). Through breakpoint-spanning PCR as well as array Comparative Genomic Hybridization (aCGH), we have identified the breakpoints and characterized the likely rearrangement mechanism of the NF1 intragenic CNCs in 85 unrelated patients. Unlike the …
-
Role of Nf1 signaling in regulating pigmentation in the mouse
… type 1 is caused by mutations in neurofibromin (NF1). Neurofibromas, which are Schwann cell based tumors, and skin hyper-pigmentation are characteristic of NF1 loss. Melanocytes differentiate from Schwann cell precursors (SCPs) during development, suggesting that there may be a mechanistic link …
-
Knowledge and Self-Esteem In Individuals With Neurofibromatosis Type 1 (Nf1)
Neurofibromatosis Type 1 (NF1) is a progressive genetic disorder characterized mainly by café-au-lait macules, Lisch nodules, as well as cutaneous and subcutaneous neurofibromas among other traits. Due to the physical manifestations of the condition, it has been observed that individuals with NF1 …
-
The role of IFITM1 in malignant progression of neurofibromas in NF1
Neurofibromatosis type 1 (NF1) is one of the most commonly inherited autosomal dominant human genetic disorder with an incidence of approximately 1 in 3000~3500 individuals worldwide. NF1 is caused by loss-of-function mutations in the NF1 gene encoding neurofibromin, a GTPase-activating protein. …
-
RMC-7977: A PROMISING INHIBITOR FOR THE TREATMENT OF NF1-RELATED TUMORS
Neurofibromatosis type 1 (NF1) is a common genetic disorder characterized by mutations in the NF1 gene, leading to the loss of neurofibromin, a RAS GTPase-activating protein, which results in the persistent activation of the RAS-MAPK signaling pathway, facilitating tumorigenesis, such as cutaneous …
-
Functional Analysis of SOX11 and NF1 in Sensory Neuron Development and Plasticity
… the protein encoded by the tumor suppressor gene Nf1, functions as a negative regulator of Ras and its two major downstream pathways: MEK-ERK and PI3K-Akt pathway. Nf1-/- embryonic sensory neurons survive without neurotrophin support attributed to enhanced PI3K activity in the absence of Nf1. In …
-
EVALUATING RATIONAL COMBINATIONS WITH GLUTAMINE ANTAGONISTS IN NF1/RAS-ACTIVE SARCOMA MODELS
… arise in patients with neurofibromatosis type 1 (NF1) and remain relatively insensitive to conventional systemic therapies. Loss of the tumor suppressor neurofibromin leads to constitutive RAS signaling and metabolic rewiring, suggesting that tumor growth may depend on biosynthetic pathways that …
-
Development of Novel Therapeutic Approaches for NF1 Deficient Peripheral Nerve Sheath Tumors
… associated with Neurofibromatosis Type 1 (NF1) pose a significant clinical challenge due to their aggressive nature and limited treatment options. This thesis endeavors to address this challenge by developing innovative therapeutic approaches for NF1-deficient PNSTs. The first objective of …
-
Functional study of the IFITM1 gene related to tumor progression of NF1
"국문요약 i 차례 iv 그림차례 v 표차례 vi Ⅰ. 서론 1 Ⅱ. 재료 및 방법 9 1. Tissue sample 9 2. Primary fibroblast 배양 10 3. 유전자 과발현을 위한 IFITM1 construct 구축 10 4. Total RNA 추출 및 cDNA 합성 12 5. RT-PCR (Reverse Transcription-PCR) 12 6. Western blot analysis 13 7. Ras activation assay 15 8. Cell death assay 15 9. Transfection …
-
Therapeutic Targeting Of Bmp2 In Nf1-Deficient Malignant Peripheral Nerve Sheath Tumors (mpnsts)
Neurofibromatosis type I (NF1)-deficient malignant peripheral nerve sheath tumor (MPNST) is an aggressive tumor for which the standard treatment is surgical removal with wide margins, often leaving behind cancer cells needing chemotherapy. RAS-GRD is the most widely studied functional target of NF1 …
-
Vitamin D Status and Muscle Function in Children with Neurofibromatosis Type 1 (NF1)
… D status and muscle function in children with NF1 compared with their unaffected siblings. Methods - NF1 children between five and 18 years of age and who had at least one unaffected sibling were identified. Serum concentrations of 25-hydroxyvitamin D, calcium, inorganic phosphate, alkaline …
-
Investigating NF1 copy number loss in high-grade serous carcinoma of the ovary
Abstract not currently available.
-
Das Phäochromozytom bei Neurofibromatose Typ 1 : Klinik und Molekulargenetik, [Untersuchung des NF1-Gens]
… 4 sowie die Neurofibromatose von Recklinghausen (NF1); die Inzidenz von Phäochromozytomen bei NF1 beträgt 0,1 - 5,7 %. Die NF1 ist eine autosomal dominante Erkrankung, deren Inzidenz bei 1:3500 Lebendgeburten liegt. Sie wird klinisch diagnostiziert. <br>Ziel der Arbeit war es, eine hohe Zahl an …
-
ZNF423 Defines a Targetable Transcriptional Dependency in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
… in individuals with neurofibromatosis type 1 (NF1). While the genetic alterations underlying malignant transformation of benign plexiform neurofibromas (PNF) to MPNST are well defined, accumulating evidence suggests that tumor progression is accompanied by aberrant reactivation of …
-
Characterization of a novel neuronal circuit essential for Nf1-dependent learning in Drosophila melanogaster
Η Drosophila melanogaster χρησιμοποιείται ευρέως για τη μελέτη της σχέσης μεταξύ γονιδίων, νευρώνων και συμπεριφοράς. Για το 75% περίπου των γονιδίων που είναι υπεύθυνα για ασθένειες στοn άνθρωπο υπάρχουν ομόλογα γονίδια στις μύγες. Επομένως, η μελέτη του νευρικού συστήματος της μύγας Drosophila …
-
Defect of Neurofibromin I (NF1) in Muscle Progenitors Induces Premature Quiescence and Metabolic Myopathy
… Ras-MAPK-ERK signaling. Mutation of the Nf1 gene leads to a reduction of neurofibromin I, which causes an autochrosomal dominated genetic disorder named neurofibromatosis type I (NF1). Clinical features have been reported in NF1 patients, including pathological changes of the …
Page 1 of 11